In a recent cancer study, Grabiner and colleagues accessed publicly available sequencing data from tumor samples to uncover 33 MTOR alterations that conferred hyperactivation of the MTOR signaling pathway within cancer cells. This evidence concerns the gene MTOR and cancer.